APA (7th ed.) Citation

Guerin, M., Egger, P., Soudant, C., Le Goff, W., van Tol, A., Dupuis, R., & Chapman, M. J. (2002). Dose-dependent action of atorvastatin in type IIB hyperlipidemia: Preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Atherosclerosis (00219150), 163(2), 287. https://doi.org/10.1016/S0021-9150(02)00037-0

Chicago Style (17th ed.) Citation

Guerin, Maryse, Pascal Egger, Céline Soudant, Wilfried Le Goff, Arie van Tol, Reynald Dupuis, and M. John Chapman. "Dose-dependent Action of Atorvastatin in Type IIB Hyperlipidemia: Preferential and Progressive Reduction of Atherogenic ApoB-containing Lipoprotein Subclasses (VLDL-2, IDL, Small Dense LDL) and Stimulation of Cellular Cholesterol Efflux." Atherosclerosis (00219150) 163, no. 2 (2002): 287. https://doi.org/10.1016/S0021-9150(02)00037-0.

MLA (9th ed.) Citation

Guerin, Maryse, et al. "Dose-dependent Action of Atorvastatin in Type IIB Hyperlipidemia: Preferential and Progressive Reduction of Atherogenic ApoB-containing Lipoprotein Subclasses (VLDL-2, IDL, Small Dense LDL) and Stimulation of Cellular Cholesterol Efflux." Atherosclerosis (00219150), vol. 163, no. 2, 2002, p. 287, https://doi.org/10.1016/S0021-9150(02)00037-0.